Search
4 articles for “Pharmacovigilance Programme of India”
-
Adverse Drug Reaction Associated with Vitamins: An Analysis of Spontaneous Reports from Pharmacovigilance Programme of India Database
Abstract: The objective of this study was to describe adverse events with the use vitamins and to identify risk factors. A retrospective study was carried out from the spontaneous adverse drug reaction (ADR) reports for the period April 2011 to March 2013 by National Coordination Centre, Pharmacovigilance Programme of India (PvPI). 29 reports of vitamins were received by NCC-PvPI, which comprised approximately 0.064% of the total 45,297 reports received at NCC-PvPI. …
Published in Research and Reviews: A Journal of Pharmacology · Vol. 5, Issue 3, 2015 · pp. 12–18 Read article
-
Participation of Nursing Professionals in Pharmacovigilance Programme of India
Abstract: Indian Pharmacopoeia Commission (IPC) functions as National Coordination Centre (NCC) for Pharmacovigilance Programme of India (PvPI) to monitor the adverse drug reactions (ADR). Healthcare professionals including nurses play a vital role in ADRs monitoring and reporting to NCC to ensure the safe use of medicines. NCC takes efforts to initiate nursing professionals to participate in PvPI to promote patients safety. To provide education and training to the nurses in ADRs …
Published in Research and Reviews: A Journal of Pharmacology · Vol. 5, Issue 2, 2015 · pp. 1–4 Read article
-
Pharmacovigilance Programme of India
Abstract: Pharmacovigilance is defined as the pharmacological science relating to the detection, assessment, understanding and prevention of adverse effects, principally long term and short term adverse effects of medicines. It is an important and integral part of clinical research. India is the world’s second most populated country with over one billion potential drug consumers. Although, India is participating in the UMC program, its contribution to the UMC database is very little. …
Published in Research and Reviews: A Journal of Pharmacology · Vol. 4, Issue 3, 2014 · pp. 13–23 Read article
-
Pharmacovigilance: The Silent Guardian of Patient Safety
Abstract: Pharmacovigilance is critical in protecting the populace health by monitoring, detecting and preventing adverse drug reaction (ADR) post drug approval. Although there is technological advancement and national initiatives such as the Pharmacovigilance Programme of India (PvPI), there is still a great problem of underreporting. Many benefits of effective pharmacovigilance include identification of risks early, better prescriptions and patient confidence. There are historical examples of drugs being withdrawn due to thalidomide, …
Published in Research and Reviews: A Journal of Pharmacology · Vol. 16, Issue 1, 2026 · pp. 01–05 Read article